Subscribe To
Gamida cell: the treacherous path to profitability
Gamida Cell's approved therapy, Omisirge, shows faster neutrophil recovery and reduced infections in blood cancer patients compared to standard care. ...
August 14, 2023, 7:02 pm
Cisco: a strong buy for risk-averse investors
Cisco Systems, Inc. has demonstrated stellar financial performance with wide free cash flow margin over the past decade. The company's capital alloca...
August 14, 2023, 3:00 pm
Global baby proofing market set to reach $370.4 bn by 2031 with 5.7% cagr growth driven by working women, daycare expansion, and safety innovations: tmr report
Rapid urbanization and rise in disposable income of the people in emerging economies and growth in the working women ...
August 14, 2023, 11:02 am
Northrim bancorp: mildly attractive even though the easy money has been made
Northrim Bancorp has shown a solid recovery, with shares down only 5.8% compared to a 36.6% drop earlier this year. The company has a strong presence ...
August 13, 2023, 8:07 am
X4 pharmaceuticals reports second-quarter 2023 financial results, provides corporate updates, and reports emerging data from chronic neutropenia clinical program
Submission of first U.S. New Drug Application for mavorixafor in WHIM syndrome on track for early 2H 2023 Emerging data from ongoing Phase 2 trial in ...
August 10, 2023, 10:05 am
Ventas: time for this reit to capitalize on the silver tsunami
REITs offer total return on investment through dividends and share price appreciation based on real estate ownership. Healthcare REITs like Ventas, In...
August 9, 2023, 2:07 pm
Kraneshares' close look at china tech hub shenzhen
KraneShares' team took a closer look at China tech hub Shenzhen this week in a visit by the asset manager's cultural analyst Xiabing Su. Shenzhen, Chi...
August 8, 2023, 2:11 pm
Assurecare unveils optimaizer: ai-driven platform revolutionizing healthcare
AssureCare’s latest product, OptimAIzer, delivers on efficiency, efficacy, and satisfaction for payors, providers, and patients CINCINNATI, Aug. 08,...
August 8, 2023, 12:08 pm
Inco: investing in one of the world's top consumption narratives
India's equities have shown stability and outperformed other emerging markets, making it a top-performing market. The Columbia India Consumer ETF prov...
August 8, 2023, 12:22 am
The food packaging market is projected to reach us$ 592.8 billion by 2033, driven by the increasing popularity of packaged foods | future market insights inc.
The rising global population and increasing disposable income are contributing to an upsurge in the dem...
August 7, 2023, 4:30 pm
Smin: best etf to buy india for long term growth
India could be a good option for international diversification, as it offers a low correlation with the U.S. and is less dependent on a weak dollar an...
August 5, 2023, 9:00 am
The economics of immigration: the u.k. vs. australia and canada
Australia and Canada are experiencing a surge in population growth, while growth rates have slowed subs...
August 2, 2023, 10:10 pm
Eicb: new 7.75% term preferred from cef eic that's worth a look
CLO CEF Eagle Point Income Co Inc is issuing another preferred - EICB - with a 7.75% coupon and a 2028 maturity. At "par," EICB has a significant yiel...
August 2, 2023, 11:26 am
Us dollar, dow jones sink as fitch downgrades us credit rating. now what?
The US Dollar and Dow Jones took a plunge after Fitch downgraded the US credit rating amid fiscal deficits and an aging ...
August 1, 2023, 11:00 pm
Mental health expert and bestselling author dr. john delony shares actionable choices to treat anxiety in new book “building a non-anxious life,” now available for presale
Nashville, Tenn., Aug. 01, 2023 (GLOBE NEWSWIRE) — According to the National Alliance on Mental Illness, anxiety disorders are the most common menta...
August 1, 2023, 9:00 am
Smin: possibly the best india etf
India is expected to become one of the main growth engines of the global economy due to its large population...
August 1, 2023, 12:03 am
Anaptysbio- and gsk-partnered immuno-oncology agent jemperli (dostarlimab-gxly) plus chemotherapy approved in the u.s. for dmmr/msi-h primary advanced or recurrent endometrial cancer
JEMPERLI is the first immuno-oncology treatment approved in the frontline setting for this patient population<...
July 31, 2023, 5:34 pm
In latin america, fintech tackles big problems with micro solutions
f fintech is meant to solve problems at the intersection of technology and finance, Latin America is a perfect place to look at. The continent is stil...
July 31, 2023, 2:09 pm
Blood coagulation analyzers market set to reach us$ 5,680.7 million by 2033 on the back of rising coagulation disorders globally | future market insights, inc.
The Global Blood Coagulation Analyzers Market is projected to experience substantial growth, with an expected value of US$ 3,038.9 Million by 2023. Se...
July 31, 2023, 1:30 am
The one thing elon musk, ray dalio, apple and goldman sachs agree on: india
Some of the biggest names in global investing and business are hailing India as the next big investment destination. The nation's booming tech scene...
July 30, 2023, 6:35 am
